Travere Therapeutic
TVTX
53.44
-2.54
-4.54%
Travere Therapeutic
US · TVTX
#2056 by market cap
Listed 1970
53.44
-2.54
-4.54%
Live - 5344 symbols - heartbeat 449s ago
· 2026-10-08 06:13
Pre-market
52.94
-0.94%
After-hours
53.44
0.00%
- Market cap
- 5.04B
- P/E (TTM)i
- -116.17
- P/Bi
- 205.54
- EPSi
- -0.29
- Div yieldi
- 0.00%
- 52W posi
- 67%
Reader sentiment
Are you bullish or bearish on TVTX?
Anonymous reader poll. Unscientific, not investment advice.
About Travere Therapeutic
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
- Founded
- 2008
- CEO
- Dr. Eric M. Dube, PhD
- Employees
- 497
- Headquarters
- San Diego, California, United States of America
- Fiscal year end
- 12-31
- Website
- travere.com
Company profile
- Exchange
- US
- Symbol
- TVTX
- Market-cap rank
- #2056
- Listing date
- 1970-01-01
- Market cap
- 5.04B
- Float cap
- 4.97B
- Shares out
- 94.26M
- Float shares
- 93.03M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-10-08 06:13:43 · For reference only, not investment advice and not tailored to your situation.